UCLA Hematology/Oncology - Pasadena is a clinical research site located in Pasadena, California, United States 91105.
Crixeo Health Trust Score: 68/100 (FAIR). This profile has not yet been claimed by the site owner.
UCLA Hematology/Oncology - Pasadena has participated in 5 clinical trials with 1 currently active.
Therapeutic areas: Metastatic Breast Cancer, HER2 Positive Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC).
Sponsors: Pfizer, Seagen, a wholly owned subsidiary of Pfizer.
Trust Score: 68/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UCLA Hematology/Oncology - Pasadena has a Crixeo Trust Score of 68/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCLA Hematology/Oncology - Pasadena has 5 clinical trials on record, with 1 currently active. Their work covers Metastatic Breast Cancer, HER2 Positive Breast Cancer, Metastatic Castration Sensitive Prostate Cancer (mCSPC).
UCLA Hematology/Oncology - Pasadena has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.